SecBot SecBot
PRESS-RELEASE ·Filed Apr 6, 2026
ST

STSS

Sharps Technology Inc
MIXED
Impact 7/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

The stock may react positively to the balance sheet turnaround and institutional crypto partnerships despite the EPS miss, but traders should monitor SOL price volatility and future staking yield sustainability as key drivers of valuation.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
STSS ▼ -28.86% at T+60d
NEUTRAL call -28.86% · α vs SPY -42.33% · entry $1.49 → $1.06
Entry = T+0 close
Apr 6, 2026
via day close
T+1d
+4.70%
call +4.70% · α +4.64%
$1.56
settled 7mo ago
T+5d
+16.11%
call +16.11% · α +11.97%
$1.73
settled 7mo ago
T+20d
+22.82%
call +22.82% · α +13.84%
$1.83
settled 6mo ago
T+60d
-28.86%
call -28.86% · α -42.33%
$1.06
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Sharps Technology reported FY2025 results showing a dramatic transformation: revenue of $7.0M (mostly $6.8M in staking income), total assets surged to $269.1M from $7.3M, and stockholders' equity grew to $264.4M after raising $430M in capital and acquiring over 2 million SOL. Despite a large EPS miss of -$4.33 (vs. $0 est), the company exited with a strengthened balance sheet, no debt, and a new Solana-focused treasury model.

Key Financial Metrics

EPS
−$4.33
est $0.00 · -320.3%
Revenue
$7.0M
est $0.00
Rating
strong miss

Key Facts

  • Reported FY2025 revenue of $7.0 million: $6.8 million from staking income (7% annualized yield), $204,120 from medical device sales
  • Total assets grew to $269.1 million (from $7.3M at end of 2024), including $250.1M in digital assets at fair value
  • Stockholders' equity increased to $264.4 million (from $2.0M), liabilities dropped to $4.7M, and $3.8M notes payable eliminated
  • Raised over $430 million in capital via equity offerings and warrant exercises to fund SOL accumulation
  • Held over 2 million SOL as of Dec 31, 2025, with ~95% staked through institutional partners like Coinbase
  • EPS of -$4.33 vs. $0 consensus — a -320.3% miss due to non-cash charges tied to capital restructuring

Financial Impact

Massive balance sheet transformation: assets up $261.8M, equity up $262.4M, driven by digital asset accumulation and capital raises

total assetsstockholders_equityrevenueepscashliabilities

Risk Factors

  • Extreme concentration risk in SOL price — a drop in SOL value could rapidly erode asset base and equity
  • Staking revenue depends on network conditions and validator performance, not guaranteed long-term
  • Regulatory uncertainty around digital asset treasuries could impact future operations or compliance costs

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3268341
2 reports for STSS
Performance horizon
Filters
Rows
Reports for STSS — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
3
NEUTRAL ★ 3/10
—awaiting T+20——
Apr 6, 2026
29w ago
Press Release
MIXED ★ 7/10
$1.49 $1.83▲ +22.82%▲ +13.84%—
Showing 2 of 2

US Market Status

Market Closed — Opens Thu (9h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 6, 2026